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Background: The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity
(POSSUM) model, its Portsmouth (P-POSSUM) modification and the Estimation of physiologic ability and surgical
stress (E-PASS) are three surgical risk scoring systems used extensively to predict postoperative morbidity and
mortality in general surgery. The aim was to undertake the first study of the predictive value of these models in
patients undergoing surgical treatment of hilar cholangiocarcinoma.
Methods: A retrospective analysis was performed on data collected prospectively over a 10-year interval from
January 2003 to December 2012. The morbidity and mortality risks were calculated using the POSSUM, P-POSSUM
and E-PASS equations.
Results: One hundred patients underwent surgical treatment of hilar cholangiocarcinoma. Complications were seen
in 52 of 100 patients (52.0%). There were 10 postoperative in-hospital deaths (10.0%). Of 31 preoperative and
intraoperative variables studied, operative type (P = 0.000), preoperative serum albumin (P = 0.003) and aspartate
aminotransferase (P = 0.029) were found to be factors multivariate associated with postoperative complications.
Intraoperative blood loss (P = 0.015), Bismuth-Corlette classification (P = 0.033) and preoperative hemoglobin
(P = 0.041) were independent factors multivariate associated with in-hospital death. The POSSUM system predicted
morbidity risk effectively with no significant lack of fit (P = 0.488) and an area under the ROC curve (AUC) of 0.843.
POSSUM, P-POSSUM and E-PASS scores showed no significant lack of fit in calculating the mortality risk (P >0.05)
and all yielded an AUC value exceeding 0.8. POSSUM had significantly more accuracy in predicting morbidity after
major and major plus operations (O:E (observed/expected) ratio 0.98 and AUC 0.901) than after minor and moderate
operations (O:E ratio 1.13 and AUC 0.759).
Conclusions: POSSUM, P-POSSUM and E-PASS scores effectively predict morbidity and mortality in surgical treat-
ment of hilar cholangiocarcinoma. However, improvements are still needed in the future because none of these
scoring systems yielded an AUC value exceeding 0.9 for operations with all different levels of severity. Only POSSUM
had more accuracy in predicting postoperative morbidity after operations with higher severity.
Trial registration: This study was undertaken after obtaining approval from the ethics committee of School of
Medicine, Shanghai Jiao Tong University with a trial registration number of 09411960800.
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In the last 20 years surgical treatment of hilar cholangio-
carcinoma has mainly evolved because of the enhanced
appreciation of tumor characteristics and improvements
in preoperative imaging [1]. However, due to complex
biliary and hepatic resections, this surgical procedure
is still considered to be one of the most challenging
procedures faced by hepatobiliary surgeons. Postopera-
tive morbidity and mortality rates remain in a high
range (14 to 76% and 0 to 19%, respectively) even in re-
ports from high-volume centers [1-5]. The accurate
prediction of outcomes after a high-risk procedure
such as surgical treatment of hilar cholangiocarcinoma
can early detect postoperative complications, allow im-
proved treatment planning and increase the precision
of individual prognosis.
Many surgical risk scoring systems have been devised,
but the Physiologic and Operative Severity Score for the
enUmeration of Mortality and Morbidity (POSSUM)
model by Copeland et al. [6] was recommended as the
most appropriate for general surgery [7,8]. This model,
utilizing scores relating to twelve physiological and
six operative variables, was developed to predict in-
hospital mortality and morbidity postoperatively. How-
ever, POSSUM was then reported as over predicting
postoperative mortality, particularly in patients at low
risk. This led to a revision: the Portsmouth modification
(P-POSSUM) by Whiteley et al. [9] Another surgical
risk scoring system that has been validated in hepato-
biliary surgery worldwide is the Estimation of Physio-
logic Ability and Surgical Stress (E-PASS) [10-12]. This
system comprises a preoperative risk score (PRS), a
surgical stress score (SSS) and a comprehensive risk
score (CRS) that is calculated from both the PRS and
SSS.
Surgical risk scoring systems were initially designed
for large populations and populations with different
pathologies. However, later they were also applied to
patients with a single diagnosis or one type of oper-
ation. It is unclear whether these two surgical risk
scoring systems are useful for predicting morbidity and
mortality in high-risk surgery such as surgical treat-
ment of hilar cholangiocarcinoma. Hellmann et al. [13]
was the first and only study to evaluate POSSUM for
the surgical treatment of cholangiocarcinoma, and they
found that the model overestimated postoperative
morbidity and mortality. However, owing to its hetero-
geneity in selection design, this study considered only
a limited and unclear number of operations for hilar
cholangiocarcinoma over a 13-year period. The aim of
the present study was to evaluate the POSSUM and E-
PASS score in surgery for hilar cholangiocarcinoma, a
most high-risk context in which to our knowledge,
they have never been applied.Methods
Patients
Data between January 2003 and December 2012 was an-
alyzed retrospectively from a prospectively maintained
database. Consecutive patients treated surgically in this
center following a diagnosis of hilar cholangiocarcinoma
were studied and only patients with histologically con-
firmed cholangiocarcinoma were included. Patients who
underwent liver transplantation were not included in
this study because a significant difference was shown in
factors associated with morbidity or mortality compared
with other types of operation.
To evaluate the different treatment strategies during
the years, these 10 years were divided into three periods
in time. Operative technique and postoperative care have
been developed during the 10 years and the last period
(2009 to 2012) was characterized by more extensive re-
sections. The operative approach in the last four years
was performed as described below [14,15]. Generally, in
patients with Bismuth-Corlette classification type I, we
performed bile duct resection only. In patients with
types II and III, an (extended) right or left hepatectomy
was performed. Patients with type IV underwent a right or
left trisectionectomy. We routinely dissected the lymph
nodes surrounding the hepatoduodenal ligament, behind
the pancreatic head and around the common hepatic
artery. Biliary continuity was achieved by Roux-en-y
hepaticojejunostomy with an isoperistaltic 70 cm limb
of jejunum. Patients underwent exploratory laparotomy
with palliative biliodigestive anastomosis or without cura-
tive intent after the surgeon found unresectable hilar
cholangiocarcinoma.
All preoperative, intraoperative and postoperative pa-
tient data (31 preoperative and intraoperative variables)
were collected and entered into a computer database
prospectively. The POSSUM, E-PASS scoring systems
and multivariate analysis were done retrospectively
from the collected data and medical records according
to defined criteria. The morbidity risk was calculated
using the POSSUM equation. The mortality risk was
calculated using the POSSUM, P-POSSUM and E-PASS
equations respectively. Complication was evaluated based
on the original POSSUM [6] and E-PASS [16] definitions
and graded according to the Clavien complication scheme
[17]. The in-hospital mortality was recorded for each
patient.
Statistical analysis
Clinical parameters were tested using the χ2 goodness-
of-fit for comparison within the three time periods.
Multivariate analysis was performed using the logistic
regression method. Frequency tables were constructed
with 10 risk bands and compared with the χ2 test using
the methods of Hosmer and Lemeshow to test the
Table 1 Characteristics of patients undergoing surgery
for hilar cholangiocarcinoma
100 patients
Age (mean) 62.9 years
Male gender (%) 48 (48.0%)
AJCC stage I/II/III/IV 7/15/17/61




Palliative biliodigestive anastomosis 31
Exploration (without curative intent) 7








Bile duct infection 4
Miscellaneous 4
Liver failure 3
Urinary tract infections 1
Biliodigestive leakage 1
Others (DIC, cerebral infarction) 2
In-hospital mortality (%) 10 (10.0%)
AJCC: American Joint Committee on Cancer; DIC: disseminated intravascular
coagulation; R0 resection: complete resection with microscopic examination of
margins showing no tumor cells; R1 resection: complete resection with no
grossly visible tumor, but examination of margins showing tumor cells; R2
resection: partial resection, with grossly visible tumor left.
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P value. In order to predicted postoperative morbidity or
mortality rate from the lowest to the highest risk in each
model the 10 risk bands were divided. Each risk band
contained the same number of subjects. Expected and
observed complications or deaths were quantified in
each band.
The discriminatory power of each model was assessed
by calculating the area under receiver-operating charac-
teristic curve (AUC). Values ranging from 0.7 to 0.9 rep-
resent reasonable discrimination. Values exceeding 0.9
represent good discrimination. The differences in mor-
bidity and mortality rate between the risk bands were
analyzed using the χ2 goodness-of-fit test. Categorical
variables were compared between groups using the χ2
test with Yates’s correction for continuity [11]. Statistical
calculations were carried out with SPSS computer soft-
ware (SPSS, Chicago, Illinois, United States). A value of
P <0.05 was considered statistically significant.
Results
Parameters and outcome
The 100 consecutive patients who underwent surgical
treatment of hilar cholangiocarcinoma during the study
period were included in the present study (Table 1).
Four of the patients had hepatolithiasis and one had liver
cirrhosis. Thirteen of the patients had diabetes, five had
hypertension and six had coronary disease. The preopera-
tive serum concentration of total bilirubin was greater
than 18 umol/L in 96 of the patients. The preoperative
hemoglobin was less than 10 g/dl in 13 of the patients.
Ten of the patients had Child’s grade A, 85 had Child’s
grade B and 5 had Child’s grade C liver status. The various
types of operation performed are shown in Table 2. Since
the second period (2006 to 2008), our center adopted new
aggressive approaches for patients with hilar cholangiocar-
cinoma, which resulted in a R0 resection rate increase
from 21% in the first period to 45% in the last period
(Table 3). Postoperative complications were seen in 52 of
100 patients (52.0%), with some patients having more than
one complication. There were 10 in-hospital deaths (10%).
The postoperative morbidity and in-hospital mortality
were not different among the three periods (P >0.05).
Multivariate analysis of factors associated with morbidity
or mortality
The thirty-one factors included in univariate analysis
for postoperative morbidity or mortality were: sex, age,
duration of disease, history of operation, pulse, blood
pressure, Child’s grade, ASA (American Society of Anaes-
thesiologists) classification, Glasgow Coma score, car-
diopulmonary diseases, diabetes mellitus, hepatolithiasis,
preoperative temperature, preoperative serum sodium,
potassium, preoperative total bilirubin, white blood cellcount, hemoglobin, prothrombin time, aspartate amino-
transferase, alanine aminotransferase, γ-glutamyl transpep-
tidase, albumin, preoperative biliary drainage, operative
type, operative duration, intraoperative blood loss, blood
transfusion, vascular resection, TNM (tumor, lymph nodes
and metastasis) stage and Bismuth-Corlette classification.
The significant factors determined by univariate ana-
lysis for postoperative morbidity were: vascular resection
(P = 0.018), preoperative serum albumin (P = 0.019), op-
erative type (P = 0.000), operative duration (P = 0.000),
intraoperative blood loss (P = 0.003), blood transfusion
(P = 0.001) and Bismuth-Corlette classification (P = 0.017).
Operative type (P = 0.000), preoperative serum albumin
(P = 0.003) and aspartate aminotransferase (P = 0.029)
were found to be factors multivariate associated with
postoperative complications (Table 3).
The significant factors determined by univariate ana-
lysis for in-hospital mortality were: preoperative serum
Table 2 Type of operation performed in 100 patients with hilar cholangiocarcinoma
Bismuth classification Operative severity
I II IIIA IIIB IV
Exploration (without curative intend) 1 1 0 1 4 Minor
Bypass operation (unresectable) 13 6 5 3 4 Moderate
Bile duct resection 13 6 6 2 12 Major
Perihilar hepatectomy 0 0 1 0 0 Major
Right hemihepatectomy 0 0 7 0 3 Major
Left hemihepatectomy 0 0 0 5 3 Major
Extended right hemihepatectomy* 0 0 2 0 0 Major+
Extended left hemihepatectomy* 0 0 0 1 1 Major+
*Combined with resection of segment 1.
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operation type (P = 0.019), intraoperative blood loss
(P = 0.001), blood transfusion (P = 0.006) and Bismuth-
Corlette classification (P = 0.014). Intraoperative blood loss
(P = 0.015), Bismuth-Corlette classification (P = 0.033) and
preoperative hemoglobin (P = 0.041) were found to be the
only independent factor multivariate associated with
in-hospital death (Table 4).
POSSUM, P-POSSUM and E-PASS scores
The calibration power of POSSUM, P-POSSUM and
E-PASS was analyzed using the Hosmer-Lemeshow
test after 10 risk bands were divided (Table 5 and
Table 6) [18]. Statistically significant differences were
detected in the postoperative morbidity or in-hospital
mortality rate between the risk bands of all three
models using the χ2 goodness-of-fit test. When com-
paring predicted morbidity with observed morbidity
by POSSUM score, an overall O:E (observed/expected)
ratio of 1.00 was found (Table 7). This model showed
no significant lack of fit (P = 0.488) and yielded an
AUC of 0.843 (Figure 1). The POSSUM, P-POSSUM
and E-PASS scores showed no significant lack of fit in
calculating the mortality risk (P >0.05). P-POSSUM
and E-PASS performed well and gave an O:E ratio of 1.00,
while POSSUM gave an O:E ratio of 1.11 (Table 7). All
scoring systems yielded an AUC value exceeding 0.8 and
none of them showed a higher AUC value in predicting
in-hospital mortality than the others (P 0.05, Table 7 and
Figure 2).Table 3 R0 resection, postoperative morbidity and in-hospita
Period 2003-2005 2006-2008
Number of patients 19 37
R0 resection 4 (21%) 11 (27%)
Morbidity 13 (68%) 15 (41%)
Mortality 4 (21%) 3 (8%)
R0 resection: complete resection with microscopic examination of margins showingTo evaluate the effect of different surgical procedures
on the predictive value of each model, all cases were
divided into four groups according to the operative se-
verity. Definitions of the operative severity were shown
in Table 2. POSSUM had significantly more accuracy
in predicting morbidity after major and major plus op-
erations (O:E ratio 0.98 and AUC 0.901) than after minor
and moderate operations (O:E ratio 1.13 and AUC 0.759,
P <0.05). However, no additional value was found for
POSSUM, P-POSSUM and E-PASS scores in predicting
in-hospital mortality after major and major plus opera-
tions (O:E ratio 1.33, 1.14, 1.33 and AUC 0.803, 0.796,
0.852) compared to those after minor and moderate oper-
ations (O:E ratio 1.00, 1.00, 0.00 and AUC 0.986, 0.973,
0.833, P >0.05).Discussion
Postoperative complications and death may result depend-
ing on three major factors: the quality of the surgical team,
the patient’s physiological status and the degree of surgical
stress [16]. Where the quality of a surgical team in one
hospital has remained stable for a certain period, surgical
risk scoring systems could be applied to assess the risk of
complications and death by quantification of the patient’s
physiological status and the surgical stress applied. Several
surgical groups have used POSSUM [17], P-POSSUM [18]
and E-PASS [12,19] successfully to perform comparative
audit in hepato-biliary-pancreatic surgery. Therefore, these
two scoring systems were chosen in the present study.l mortality in relation to the different periods
2009-2012 Total P
44 100
20 (45%) 34 (34%) 0.091
24 (55%) 52 (52%) 0.128
3 (7%) 10 (10%) 0.255
no tumor cells.
Table 4 Significant multivariate associations between
study variables and postoperative morbidity and
in-hospital mortality
OR 95% CI P
Morbidity
Operation type 6.661 3.058-14.509 0.000
Preoperative serum albumin, mg/dL 0.194 0.065-0.583 0.003
Aspartate aminotransferase (AST), U/L 10.304 1.268-83.754 0.029
Mortality
Intraoperative blood loss, ml 3.259 1.262-8.416 0.015
Bismuth classification 0.154 0.028-0.859 0.033
Preoperative hemoglobin, g/l 1.973 1.028-3.787 0.041
CI: confidence interval; OR: odds ratio.
Table 6 Calibration power of POSSUM score for
predicting postoperative morbidity
POSSUM P-POSSUM E-PASS
Risk band E O E O E O
1 0 0 0 0 1 0
2 0 0 1 0 0 0
3 0 0 0 0 0 0
4 0 0 0 0 1 1
5 0 0 1 1 1 1
6 0 1 1 1 1 1
7 1 2 1 1 1 2
8 1 0 1 1 2 3
9 2 3 2 3 3 2
10 5 4 4 3 - -
Total 9 10 10 10 10 10
POSSUM: Physiological and Operative Severity Score for the enUmeration of
Mortality and morbidity; P-POSSUM: Portsmouth modification of POSSUM;
E-PASS: Estimation of physiologic ability and surgical stress; E: expected;
O: observed.
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applied to a specific hilar cholangiocarcinoma surgical
patient population. With a postoperative morbidity rate
of 52.0% and an in-hospital mortality rate of 10.0%, our
institution lies within the accepted range of complications
after surgical treatment of hilar cholangiocarcinoma [1].
When the χ2 test was used to compare actual morbidity
and mortality rates with estimated ones, there was no sig-
nificant lack of fit (P >0.05), indicating that the POSSUM
and E-PASS scoring systems accurately estimate the out-
comes. They also yielded an AUC value exceeding 0.7,
suggesting their utility in predicting morbidity and mortal-
ity after surgery for hilar cholangiocarcinoma. However,
improvements are still needed in the future because none
of these scoring systems yielded an AUC value exceeding
0.9 for operations with all different levels of severity. Previ-
ous meta-analysis [20] and some reports [10] revealed that
the POSSUM and E-PASS scoring systems failed to offer a
significant predictive value for morbidity and mortalityTable 5 Calibration power of POSSUM score for
predicting postoperative morbidity
POSSUM












POSSUM: Physiological and Operative Severity Score for the enUmeration of
Mortality and morbidity; E: expected; O: observed.after hepatobiliary surgery. The main reason for the differ-
ent findings may be that surgery of hilar cholangiocarci-
noma is a more complex and severe operation than other
hepatobiliary procedures. It has a higher operative severity
score in POSSUM and a higher surgical stress score in
E-PASS and therefore results in a higher risk prediction.
Because the potential for morbidity and mortality is
greater after this operation, surgical risk scoring systems
would demonstrate a more accurate predictive value.
We evaluated the corresponding results if only the pa-
tients underwent major and major plus operations were
included. POSSUM indeed had more accuracy in pre-
dicting postoperative morbidity after major and major
plus + operations. Similar findings have been observed
in other studies, where POSSUM has a significantly
more accurate predictive value for higher acuity proce-
dures, such as pancreaticoduodenectomy, than for otherTable 7 Predictive value of four surgical risk scoring
systems of postoperative morbidity and in-hospital
mortality
O/E ratio P* AUC** (95% CI)
Morbidity
POSSUM 1.00 (52/52) 0.488 0.843 (0.768-0.919)
Mortality
POSSUM 1.11 (10/9) 0.520 0.863 (0.766-0.961)
P-POSSUM 1.00 (10/10) 0.721 0.848 (0.740-0.956)
E-PASS 1.00 (10/10) 0.671 0.842 (0.735-0.949)
*: goodness-of-fit analysis.
**: receiver operating characteristic curve.
POSSUM: Physiological and Operative Severity Score for the enUmeration of
Mortality and morbidity; P-POSSUM: Portsmouth modification of POSSUM;
E-PASS: Estimation of physiologic ability and surgical stress.
















1 – Specificity (rate)
Figure 1 ROC curve for POSSUM predicting postoperative
morbidity in surgical treatment of hilar cholangiocarcinoma.
ROC curve: receiver operating characteristic curve; POSSUM:
Physiological and Operative Severity Score for the enUmeration of
Mortality and morbidity.
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value was found for POSSUM, P-POSSUM and E-PASS
scores in predicting in-hospital mortality after major
and major plus operations. Firstly, operative type was
not a factor multivariate associated with postoperative
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Figure 2 ROC curve for POSSUM, P-POSSUM and E-PASS scores
predicting in-hospital mortality in surgical treatment of hilar
cholangiocarcinoma. ROC curve: receiver operating characteristic
curve; POSSUM: Physiological and Operative Severity Score for the
enUmeration of Mortality and morbidity; P-POSSUM: Portsmouth
modification of POSSUM; E-PASS: Estimation of physiologic ability
and surgical stress.whether the type of operation influences the validity of
the scores. Secondly, some independent factors for mor-
bidity and mortality, such as operation type, intraopera-
tive blood loss and preoperative hemoglobin are scored
in POSSUM, P-POSSUM and E-PASS. Multivariate pre-
dictors for hepatobiliary surgery may differ from those in
POSSUM and E-PASS scoring systems [22]. Based on the
findings of our multivariate analysis, preoperative serum
albumin, aspartate aminotransferase, and the Bismuth
classification are independent factors associated with
postoperative morbidity or in-hospital mortality but are
included neither in E-PASS nor in POSSUM systems.
Therefore, if researchers would like to improve the
AUC value of these surgical scoring systems for hilar
cholangiocarcinoma in the future, these factors might
be added as new parameters in revised models.
Among the three surgical risk scoring systems employed
in the present study, none of them showed a higher AUC
value in predicting in-hospital mortality than the others.
The advantage of the E-PASS scoring system is the relative
ease with which data are acquired. This is favorable to the
POSSUM or P-POSSUM score, which requires 18 differ-
ent variables compared with the nine variables needed for
the E-PASS score [23]. Furthermore, the POSSUM was
generated only for surgical auditing and not for surgical
decision making. However, the application of E-PASS has
a potential role not only in surgical auditing but also in
surgical decision making both between and within individ-
ual practice [24]. In our institution, we have developed
preoperative management scenarios in our pancreato-
biliary surgical practice. For example, patients with a high
comprehensive risk score (CRS) are provided additional
preoperative interventions such as enteric tube feedings,
hyperalimentation, antibiotics, and biliary stenting, to im-
prove preoperative parameters. This is often indicated,
particularly when patients present with malignant ob-
structive jaundice, comorbid cardiac or respiratory illness,
diabetes, or malnutrition.
There are some limitations to the present study.
Firstly, since hilar cholangiocarcinoma is an uncommon
neoplasm, the mortality rate corresponds to only ten pa-
tients, resulting in a relatively small group (100 patients)
available for analysis over a long period of time (2003 to
2012). Operative technique and postoperative care have
been developed during the past 10 years and treatment
strategies are evolving. Secondly, in constructing the
E-PASS model postoperative complications were only
included when medical or interventional treatment
had been carried out and mild complications were not
regarded to be the same as severe ones [16]. However,
POSSUM and P-POSSUM use a different definition
and analysis of complication [6] which may affect the
comparison of predictive value of scoring systems in
our study.
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The present study shows that POSSUM, P-POSSUM
and E-PASS scores effectively predict morbidity and
mortality in surgical treatment of hilar cholangiocarci-
noma. However, improvements are still needed in the
future because none of these scoring systems yielded an
AUC value exceeding 0.99 for operations with all differ-
ent levels of severity. Only POSSUM had more accuracy
in predicting postoperative morbidity after operations
with higher severity.
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